The 133rd Canton Fair Gathers Top Medical Equipment to Unlock the Health Code

GUANGZHOU, China, May 19, 2023 /PRNewswire/ — Global healthcare takes center stage as the world recovers from the COVID-19 pandemic. As the public becomes more vigilant about their health, medical institutions are also stepping up their game in providing top-notch services and equipment. In the 133rd Canton Fair, over 700 companies showcased their latest offerings of … Read more

Bipartisan, Bicameral PACE Part D Choice Act Would Reduce Part D Costs and Increase Access for Medicare Beneficiaries to Innovative Programs of All Inclusive Care for the Elderly

WASHINGTON, May 19, 2023 /PRNewswire/ — This week, U.S. Representatives Brad Wenstrup, MD (R-OH) and Earl Blumenauer (D-OR3) and U.S. Senators Tom Carper (D-DE) and Bill Cassidy, MD (R-LA) introduced The PACE Part D Choice Act, which would eliminate a significant financial disincentive for Medicare-only beneficiaries to enroll in Programs of All-Inclusive Care for the Elderly … Read more

Patient Advocate Foundation’s Most Popular Resource Just Got Better

National Financial Resource Directory Delivers the Daily Assistance Patients Need, Today HAMPTON, Va., May 19, 2023 /PRNewswire/ — With over 100 million Americans carrying healthcare-related debt and the need for free resources and assistance soaring, the Patient Advocate Foundation (PAF) announced the re-launch of the award-winning National Financial Resource Directory. The directory is the most … Read more

Decentralized Clinical Trial Strategies to Enhance Patient Satisfaction and Future Participation:, Explore the Rationale for Not Participating in Clinical Trials

DUBLIN, May 19, 2023 /PRNewswire/ — The “DCT Strategies to Enhance Patient Satisfaction and Future Participation – 2022” report has been added to  ResearchAndMarkets.com’s offering. The report examines perceptions of 360 clinical trial participants and 440 respondents from the general population that have not participated in a clinical trial. In this report the publisher takes a … Read more

Another Hisense HD60 Ultrasound Installation at Vaal Radiology, South Africa

CAPE TOWN, South Africa, May 19, 2023 /PRNewswire/ — Hisense, a manufacturer and provider of high-performance electronics and medical devices, has recently installed the Hisense Ultrasound HD60 at Vaal Radiology, a medical imaging center in Vereeninging, South Africa. This color Doppler ultrasound system is ideal for various ultrasound applications including general abdominal, vascular, and small parts. … Read more

10 Stories You Need to See

A roundup of the week’s most newsworthy health industry press releases from PR Newswire, including the FDA approval of a medication to moderate hot flashes. NEW YORK, May 19, 2023 /PRNewswire/ — With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists … Read more

Global Pharma, Biotech & Diagnostics Collaborative R&D Partnering Analysis Report 2023 with a Directory of Over 6,000 Deals Signed Since 2016

DUBLIN, May 19, 2023 /PRNewswire/ — The “Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2016-2023” report has been added to  ResearchAndMarkets.com’s offering. The Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 report provides comprehensive understanding and unprecedented access to 6,000+ collaborative R&D deals and agreements … Read more

Optellum’s Clinical Partners Present at ATS International Conference 2023

Clinicians from top US healthcare centers demonstrate the benefits of AI-assisted early lung cancer diagnosis at this year’s American Thoracic Society (ATS) International Conference WASHINGTON, May 19, 2023 /PRNewswire/ — Optellum, a medtech company that provides a ground-breaking AI platform to diagnose and treat early-stage lung cancer, is attending this year’s American Thoracic Society International Conference … Read more

RZNOMICS Inc. received FDA approval to initiate clinical development of trans-splicing ribozyme-based RNA editing technology in Glioblastoma Multiforme Patients

SEONGNAM, South Korea, May 19, 2023 /PRNewswire/ — Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, recently received Phase 1/2a IND approval from the U.S FDA on May 6th for its Glioblastoma Multiforme (GBM) treatment called RZ-001 and thus has achieved an important milestone for the company and … Read more

Study Shows PulseAI’s Deep Learning Algorithm Outperforms the Apple Watch ECG Algorithm in Detecting Atrial Fibrillation

BELFAST, Northern Ireland, May 19, 2023 /PRNewswire/ — PulseAI, a leader in the development of cutting-edge AI-powered ECG software, has released the results of a clinical study that has shown the superiority of its deep learning AI over the Apple Watch ECG algorithm in the detection of atrial fibrillation (AF). The study was conducted by a … Read more